Skip to main content
glpverdict
Subscribe⊙Sign in
🔍12+ medical reviewers in network🏆FDA & peer-reviewed sources📈Updated weekly🩺Medically reviewed content

Newsletter

Weekly GLP-1 updates, no filler

Shortages, savings, new approvals, and reviewer-vetted guidance. 5 min/week.

Free Week-1 Survival Kit PDF on signup· 5,400+ readers · weekly · unsubscribe anytime

glpverdict

Evidence-based GLP-1 reviews. Medically reviewed, affiliate-funded, editorially independent.

Language

EnglishEspañol

Compare providers

  • Best overall
  • Cheapest
  • Best rated
  • Accepts insurance
  • Most medications
  • Side-by-side

Medications

  • Wegovy
  • Ozempic
  • Zepbound
  • Mounjaro
  • Saxenda
  • Rybelsus
  • All medications

Tools

  • Match me to a provider
  • Eligibility checker
  • Weight-loss projection
  • PAP eligibility
  • Symptom triage
  • Insurance coverage
  • All tools

Coverage & savings

  • Insurance appeals
  • GLP-1 cost by state
  • Cost trends
  • Compounded vs brand
  • Switching guides
  • Shortage tracker
  • Drug pipeline

Research & editorial

  • Primary-data research
  • GLP-1 Diaries
  • News + recalls
  • Lawsuit + MDL tracker
  • Q&A library
  • Glossary
  • Editorial board
  • Editorial standards
  • Press kit

GLP-1 by audience

  • Sleep
  • Fitness
  • Mental health
  • Pediatric
  • Veterans
  • Medicare
  • Seniors
  • Men
  • Postmenopausal
  • Trans + gender-diverse
  • Post-bariatric

For informational purposes only. Not medical advice. Talk to a licensed clinician before starting, stopping, or switching medication. © 2026 Glpverdict.

  • Medically reviewed
  • FDA + peer-reviewed
  • Updated weekly
  • Independent ranking
HomeTop picksMedsQuizSaved
HomeCompareMounjaro vs Wegovy

Medication comparison

Mounjaro vs Wegovy

Mounjaro and Wegovy are both prescription medications (GIP/GLP-1 dual receptor agonist vs GLP-1 receptor agonist) used for Type 2 diabetes and Chronic weight management. The table below compares FDA-approved indications, dosing, weight-loss outcomes, side effects, contraindications, and current pricing — all sourced from the manufacturer prescribing information.

This is general drug information, not medical advice. Talk to a licensed clinician before starting, stopping, or switching medication.

Drug A

Mounjaro

tirzepatide

GIP/GLP-1 dual receptor agonist

Eli Lilly

See full overview
VS

Drug B

Wegovy

semaglutide

GLP-1 receptor agonist

Novo Nordisk

See full overview
PropertyMounjaroWegovy
Generic nametirzepatidesemaglutide
Drug classGIP/GLP-1 dual receptor agonistGLP-1 receptor agonist
ManufacturerEli LillyNovo Nordisk
Approved indicationsType 2 diabetesChronic weight management
Brand namesMounjaroWegovy
Typical dosingTitrate to 15 mg (weekly SC injection)Titrate to 2.4 mg (weekly SC injection)
Top side effectsNausea (29.6%), Diarrhea (23%), Vomiting (12.6%)Nausea (44.2%), Diarrhea (31.5%), Vomiting (24.8%)
Contraindications——
Boxed warningYesYes
PregnancyC — Discontinue at least 1 month before a planned pregnancy.C — Discontinue at least 2 months before a planned pregnancy.
StorageRefrigerate before first use. After first use, room temperature up to 21 days.Refrigerate before first use. After first use, room temperature up to 28 days.
Avg monthly cost$1023.04$1349.02

FDA boxed warning

Mounjaro: Risk of thyroid C-cell tumors. Contraindicated in patients with personal or family history of medullary thyroid carcinoma (MTC) or multiple endocrine neoplasia syndrome type 2 (MEN 2).

Wegovy: Risk of thyroid C-cell tumors. Contraindicated in patients with personal or family history of medullary thyroid carcinoma (MTC) or multiple endocrine neoplasia syndrome type 2 (MEN 2).

Already on Mounjaro and considering Wegovy?

Tirzepatide → semaglutide for weight loss specifically — insurance or formulary driven.

Read the switching guide

Frequently asked

What is the difference between Mounjaro and Wegovy?

Mounjaro is tirzepatide (GIP/GLP-1 dual receptor agonist) and Wegovy is semaglutide (GLP-1 receptor agonist). They have different active ingredients and slightly different side-effect profiles.

Is Mounjaro or Wegovy more effective for weight loss?

Head-to-head trial data favors tirzepatide-based medications (Mounjaro, Zepbound) over semaglutide-based medications (Ozempic, Wegovy) in average percent weight loss. See each drug's clinical-trials section for SURMOUNT and STEP trial data.

Can I switch between Mounjaro and Wegovy?

Yes — see our directional switching guide at /switching/mounjaro-to-wegovy for FDA-label dose conversion and what to expect during the transition.

More medication context

Tools and guides that pair with this comparison.

  • Overview

    Mounjaro full overview

    tirzepatide mechanism, dosing, side effects, and pricing.

    Read
  • Overview

    Wegovy full overview

    semaglutide mechanism, dosing, side effects, and pricing.

    Read
  • Live data

    GLP-1 shortage tracker

    Real-time FDA shortage status by drug and dose.

    Read
  • Free tool

    Are you a candidate?

    FDA-criteria decision tree, flags contraindications.

    Read
  • Free tool

    Prior auth letter generator

    Payer-ready PA letter your prescriber can sign.

    Read
  • Live data

    12-month price trends

    How telehealth provider pricing has moved over the past year.

    Read
People also ask

Common questions readers ask

Can you drink alcohol on Wegovy?
No hard contraindication, but alcohol tolerance often drops sharply on GLP-1. Many patients also report reduced desire for alcohol — likely a secondary effect of GLP-1 on the brain reward system.
Full evidence-graded answer
Does GLP-1 affect oral birth control?
Tirzepatide (Mounjaro, Zepbound) has documented reduced absorption of oral contraceptives during the first 4 weeks of each dose increase. Use backup contraception for ~4 weeks after starting + after each step-up. Semaglutide has no documented effect.
Full evidence-graded answer
Can I take GLP-1 while pregnant?
No. All FDA-approved GLP-1s carry a pregnancy contraindication. Stop GLP-1 at least 2 months before planned conception due to its long half-life.
Full evidence-graded answer
Is it safe to take GLP-1 long-term?
Liraglutide has 15+ years of post-marketing data (Victoza approved 2010). Semaglutide has 8+ years (Ozempic approved 2017). No new class-wide safety signals have emerged in extended follow-up. Chronic use is the FDA-approved indication for both T2D and obesity.
Full evidence-graded answer
Do I need to exercise on Wegovy?
Yes — resistance training specifically. Without it, 25-40% of weight lost on GLP-1 comes from lean muscle. Cardio is a bonus; resistance is the non-negotiable.
Full evidence-graded answer

Affiliate disclosure: we earn commissions when readers sign up through our links. Editorial ranking is independent.